% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • nicnac1027 nicnac1027 May 8, 2013 2:29 PM Flag

    Price target. Not sure how credible this is but. $4.75

    Affymax Inc. (NASDAQ:AFFY) shares are trading up by 40.86% at $1.62. The biopharmaceutical company, which sells drugs for the treatment of life-threatening conditions, is seeing a huge upswing as the stock is opened at 1.17 and has a range of 1.13 and 1.65. Volume is 27.12 million shares. Affymax has a market capitalization worth $60.97 million. The reason behind the soaring shares, according to analysts, is based on a rumor that the company’s diabetes drug could make a comeback. AFFY is also facing a lawsuit alleging that company didn’t reveal the side-effects of its OMONTYS (peginesatide) Injection used for anemia treatment. On February 23, 2013 Affymax and Takeda Pharmaceutical issued an announcement of a nationwide voluntary recall of OMONTYS. On April 2, Affymax announced fourth quarter result with the net loss of $68.3 million, or $1.85 loss per share, compared to a $29.4 million net loss, or $0.82 loss per share reported on the same quarter in 2011. The company is yet to announce its first quarter results for the year 2013. Investment analysts have set $4.75 target price on Affymax shares.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.070.0000(0.00%)Sep 28 12:24 PMEDT